Zoetis Company Presentation

ZOETIS: LEADING ANIMAL HEALTH ACROSS THE CONTINUUM OF CARE • Global leader in an attractive market with sustainable growth drivers and opportunities ● ● Diverse and durable portfolio with proven strength in innovation 4 Track record of delivering strong financial results and disciplined capital allocation • Clear strategic priorities to deliver continued above-market growth and long-term value $6.3B 2019 REVENUE +336% TOTAL SHAREHOLDER RETURN SINCE IPO THOUGH DEC. 31, 2019³ -300 NUMBER OF PRODUCT LINES ACROSS 8 SPECIES 10% OPERATIONAL REVENUE GROWTH 1 45 COUNTRIES WITH DIRECT PRESENCE ¹ Operational revenue growth (a non-GAAP financial measure) is defined as growth excluding the impact of foreign exchange. 2 Total Shareholder Return (TSR) represents the total return between 2/1/13 (first day of ZTS trading) and 12/31/19; if the IPO date of 1/31/13 were used, TSR would be 420%. Calculation does not include reinvestment of dividends. 1,100+ NEW PRODUCTS & LIFECYCLE INNOVATIONS INTRODUCED IN THE LAST 5 YEARS zoetis

View entire presentation